Sitemap | Feedback

Advanced search

Journal of Case Reports

Poroid Hidradenoma: A Rare Tumor Entity

lexapro pregnancy autism

lexapro pregnancy safety

buscopan

buscopan prezzo

Mohammad Rahmati Roodsari1, Hamed Abdolghafoorian2, Mohammad Saiedi1

From the Skin Research Center1, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Shahid Beheshti University of Medical Sciences2, Tehran, Iran.

Corresponding Author:
Dr. Mohammad Saiedi Email: rahelehsajadinia@yahoo.com

Received: 22-AUG-2013

Accepted: 30-OCT-2013

Published Online: 10-DEC-2013

DOI:	http://dx.doi.org/10.17659/01.2013.0102

Abstract

Poroid hidradenoma is a rare cutaneous neoplasm, most frequently situated on head and neck. It presents architectural features of hidradenoma, with solid and cystic areas and tumor cells restricted to the dermis, and cytological features of poroid neoplasm such as poroid and cuticular cells. This neoplasm is a new entity which is closely related to proma family. Similar to most of other adnexal tumors, treatment is based on surgical resection in order to prevent a possible recurrence or malignant transformation. To date, very few cases of this entity have been reported in the literature. We present a case of poroid hidradenoma in a 61-year-old woman with a soft-tissue lesion on her neck.

Keywords :

Adenoma, Sweat Gland Neoplasms, Acrospiroma, Neck, Neoplasm Recurrence.

Article Options

FULL TEXT
ABSTRACT
PDF

PRINTER FRIENDLY VERSION

Search PubMed for

Search Google Scholar for

Article Statistics

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

Last updated on Jan 02, 2025